Organon & Co.
Public profile▸✏️ Suggest a correction
📡 Recent posts· 0
📊 Financial
▾ 📰 Recent news
-
Organon's Supplemental Biologics License Application Gets FDA Approval For TOFIDENCE To Treat Chimeric Antigen Receptor T Cell-Induced Severe Or Life-Threatening Cytokine Release Syndrome
Organon (NYSE:OGN) today announced the US Food and Drug Administration (FDA) approval of the supplemental Biologics License Application (sBLA) for TOFIDENCE® (tocilizumab-bavi) injection, for intravenous use, a
AI is researching subsidiaries, segments, key people (founders / execs / board), and related books. Usually 15–45 seconds.
📚 Books · 0
🎥 Playlists featuring Organon & Co. · 0
➕ Sign in to add a playlist. It surfaces here, on your personal playlists page, and on every twin course at every school.
▸📺 Videos
· searching YouTube…
Searching YouTube for recent videos about Organon & Co.… know one? Suggest it below.
➕ Suggest a YouTube video
Your suggestion appears immediately for all visitors. Must be a public YouTube video relevant to Organon & Co..
Quotes· 0
⭐ Reviews · 0
Replies ingeneral· 0
Every shadow page is its own thread. Add a thought, reply to others, come back later.